会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • SYRINGE, AND SAFETY DEVICE FOR SYRINGE NEEDLE
    • SPRITZE UND SICHERHEITSVORRICHTUNGFÜRSPRITZENNADEL
    • EP3127573A1
    • 2017-02-08
    • EP15772842.9
    • 2015-02-12
    • NIPRO CORPORATION
    • HASEGAWA, Mitsuru
    • A61M5/32
    • A61M5/3275A61M5/321A61M5/3243A61M5/3257
    • A syringe (1) includes a barrel (10), a plunger, an injection needle (30), and an injection needle safety instrument (40). The injection needle safety instrument (40) has a base portion (41) fixed to the barrel (10), a cover portion (42) which can cover a pointed end of a needle tube (31) included in the injection needle (30), and a hinge portion (43) which pivotably couples the base portion (41) and the cover portion (42) to each other. The cover portion (42) is constructed to be pivotable between a first position at which the cover portion is held to the base portion (41) as a first locked portion (42c) is locked by a locking portion (41c) of the base portion (41) and a second position at which the cover portion covers the pointed end of the needle tube (31) and is held to the injection needle (30) as a second locked portion (42b) is locked to the injection needle (30). The cover portion (42) is tilted toward the barrel (10) while it is arranged in the first position.
    • 注射器(1)包括筒(10),柱塞,注射针(30)和注射针安全器械(40)。 注射针安全器具(40)具有固定在枪管(10)上的基部(41),能够覆盖注射针(30)内的针管(31)的尖端的盖部(42) ,以及可枢转地将基部(41)和盖部分(42)彼此可枢转地联接的铰链部分(43)。 盖部分(42)被构造成可以在第一位置和第二位置之间枢转,第一位置将盖部分保持在基座部分(41)上,因为第一锁定部分(42c)被基部的锁定部分 (41)和覆盖部分覆盖针管(31)的尖端的第二位置,并且当第二锁定部分(42b)被锁定到注射针头(30)时,第二位置被保持到注射针头(30) 。 盖部分42被布置在第一位置时朝向筒体10倾斜。
    • 6. 发明公开
    • INSTRUMENT FOR SUPPRESSING DRUG CRAVING AND KIT FOR SUPPRESSING DRUG CRAVING
    • 仪器ZURUNTERDRÜCKUNGVON DROGENSUCHT UND KIT ZURUNTERDRÜCKUNGVON DROGENSUCHT
    • EP2210630A1
    • 2010-07-28
    • EP08838692.5
    • 2008-10-15
    • National Hospital OrganizationNIPRO CORPORATION
    • HIRAI, ShinjiHASEGAWA, MitsuruOHGURO, Takeshi
    • A61M5/00
    • The kit for suppressing drug craving K is used by connecting an instrument for suppressing drug craving 1 to a syringe 2 and the instrument for suppressing drug craving 1 has a cylindrical housing 11, a pouch 12 provided in the housing and containing pseudo-blood B and a connecting member 13 with which the distal end of a syringe is coupled and which cause the syringe to communicate with the interior of the pouch. When the syringe accommodating pseudo-drug M is connected to the instrument and the plunger is moved forward (pseudo-priming), the pseudo-drug M flows into a pouch and the pouch inflates ( Figure 2(b) ), and if the plunger 4 is pulled back from this condition, the pouch 12 deflates and the pseudo-blood B flows back from the pouch 12 to the syringe 2 (flashback) ( Figure 2(C) ). This allows people other than health care professionals or even a drug addict to safely use the kit and allows the therapy to be effectively conducted by allowing the drug addict to associate with the act of administering a drug in a pseudo-manner.
    • 用于抑制药物渴望K的试剂盒通过将用于抑制药物渴望的仪器1连接到注射器2而使用,并且用于抑制药物渴望的仪器1具有圆柱形壳体11,设置在壳体中并包含假血液B的袋12, 连接构件13,其与注射器的远端联接并且使得注射器与袋的内部连通。 当将装有假药M的注射器连接到仪器并且柱塞向前移动(假起动)时,假药M流入袋中并且袋膨胀(图2(b)),并且如果柱塞 4从该状态被拉回,袋12放气,假血B从袋12流回注射器2(回闪)(图2(C))。 这使得医护人员以外的人甚至吸毒者可以安全地使用药盒,并允许药物成瘾者以伪造方式与药物的作用相关联,从而有效地进行治疗。
    • 9. 发明公开
    • PREFILLED SYRINGE
    • VORGEFÜLLTESPRITZE
    • EP3075403A1
    • 2016-10-05
    • EP14866233.1
    • 2014-11-05
    • Nipro Corporation
    • HASEGAWA, MitsuruHONDA, Minoru
    • A61M5/28A61M5/315
    • A61M5/31596A61M5/19A61M5/284A61M5/31501A61M5/31505A61M5/31513A61M5/3202A61M2005/3131A61M2005/3132A61M2005/31508
    • A pre-filled syringe (1) includes: a cylindrical container (2), a front end-side gasket (30); a rear end-side gasket (40); an intermediate gasket (50) partitioning an inside of the cylindrical container (2) into a front chamber (13) and a rear chamber (14); a plunger (60); a medical drug (5) contained in the front chamber (13), and a liquid drug (6) contained in the rear chamber (14). In the state where the plunger (60) is pushed in, a bypass portion (15) included in the cylindrical container (2) faces a groove portion (52) provided in the intermediate gasket (50), thereby allowing communication between the front chamber (13) and the rear chamber (14) therethrough, so that the medical drug (5) and the liquid drug (6) are mixed, and a liquid mixture is discharged. The pre-filled syringe (1) further includes a movement limiting mechanism for limiting movement of the plunger (60) such that a tail end (40b) of the rear end-side gasket (40) does not reach the bypass portion (15).
    • 预填充注射器(1)包括:圆柱形容器(2),前端侧垫圈(30); 后端侧垫圈(40); 将所述圆筒形容器(2)的内部分隔成前室(13)和后室(14)的中间垫圈(50)。 柱塞(60); 包含在前室(13)中的药物(5)和容纳在后室(14)中的液体药物(6)。 在柱塞60被推入的状态下,包括在圆筒形容器2中的旁通部分15面对设置在中间垫圈50中的槽部52,从而允许前室 (13)和后室(14)通过,使医药(5)和药液(6)混合,排出液体混合物。 预填充注射器(1)还包括用于限制柱塞(60)的运动的移动限制机构,使得后端侧衬垫(40)的尾端(40b)不到达旁路部分(15) 。